[1]
J. Hawkes, J. Guercio, S. Kurup, X. Li, and M. Lebwohl, “Expected Spesolimab Plasma Exposure following Intravenous and Subcutaneous Dosing in Patients with Generalized Pustular Psoriasis”, J of Skin, vol. 8, no. 2, p. s359, Mar. 2024.